Professor Sandor Vajda

Professor of Biomedical Engineering and Chemistry

Sandor Vajda received M.S. in Electrical Engineering in Moscow, Russia, and M.S. in Applied Mathematics and Ph.D. in Chemistry, both in Budapest, Hungary. He held research positions in the Department of Engineering, University of Warwick, England, and the Department of Chemistry, Princeton University. He was on the faculty of the Eotvos Lorand University, Budapest, Hungary and the Mount Sinai School of Medicine, New York, NY. Currently he is Professor of Biomedical Engineering and Chemistry at Boston University. He also directs the Biomolecular Engineering Research Center at BU. Dr. Vajda has been active in method development for modeling of biological macromolecules, with focus on two problems. The first is the analysis of protein-protein interactions, including protein docking, antibody maturation, and protein aggregation. The second broad area includes the characterization of protein binding sites, target identification, druggability assessment, and the development of computational methods for fragment based drug discovery. In 2004 he and his graduate students founded SolMap Pharmaceuticals, a start-up company focusing on fragment-based drug design. SolMap was acquired by Forma Therapeutics, Cambridge, MA, in 2008. He is currently the CSO of another drug discovery software development startup, Acpharis Inc.